scholarly article | Q13442814 |
P356 | DOI | 10.1034/J.1600-0684.2003.00027.X |
P8608 | Fatcat ID | release_sbsix2fm5zdhtlewhdh5vo53y4 |
P953 | full work available online at | https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1034%2Fj.1600-0684.2003.00027.x |
https://onlinelibrary.wiley.com/doi/pdf/10.1034/j.1600-0684.2003.00027.x | ||
P698 | PubMed publication ID | 14498981 |
P2093 | author name string | M. Hsu | |
J. Blanchard | |||
J. E. Robinson | |||
C. Buckner | |||
C. Cheng-Mayer | |||
A. Gettie | |||
J. Harouse | |||
P2860 | cites work | Structure of an HIV gp120 envelope glycoprotein in complex with the CD4 receptor and a neutralizing human antibody | Q27759364 |
HIV Entry and Its Inhibition | Q28273919 | ||
The antigenic structure of the HIV gp120 envelope glycoprotein | Q28274698 | ||
A Conserved HIV gp120 Glycoprotein Structure Involved in Chemokine Receptor Binding | Q28646883 | ||
Vpr is required for efficient replication of human immunodeficiency virus type-1 in mononuclear phagocytes | Q29619514 | ||
Changes in human immunodeficiency virus type 1 envelope glycoproteins responsible for the pathogenicity of a multiply passaged simian-human immunodeficiency virus (SHIV-HXBc2) | Q33640139 | ||
Mucosal transmission and induction of simian AIDS by CCR5-specific simian/human immunodeficiency virus SHIV(SF162P3) | Q33855093 | ||
Persistent infection of rhesus macaques with T-cell-line-tropic and macrophage-tropic clones of simian/human immunodeficiency viruses (SHIV) | Q34060230 | ||
Increased mucosal transmission but not enhanced pathogenicity of the CCR5-tropic, simian AIDS-inducing simian/human immunodeficiency virus SHIV(SF162P3) maps to envelope gp120. | Q34464860 | ||
Involvement of the V1/V2 variable loop structure in the exposure of human immunodeficiency virus type 1 gp120 epitopes induced by receptor binding | Q35845976 | ||
Characterization of molecularly cloned simian-human immunodeficiency viruses causing rapid CD4+ lymphocyte depletion in rhesus monkeys | Q35885915 | ||
Change in coreceptor use correlates with disease progression in HIV-1--infected individuals | Q36376800 | ||
The Envelope Glycoprotein Ectodomains Determine the Efficiency of CD4+ T Lymphocyte Depletion in Simian– Human Immunodeficiency Virus–Infected Macaques | Q36401769 | ||
Macrophage tropism of human immunodeficiency virus type 1 and utilization of the CC-CKR5 coreceptor. | Q38943221 | ||
Identification of the envelope V3 loop as the primary determinant of cell tropism in HIV-1. | Q39090316 | ||
Emerging cytopathic and antigenic simian immunodeficiency virus variants influence AIDS progression. | Q39137553 | ||
Envelope glycoprotein determinants of increased fusogenicity in a pathogenic simian-human immunodeficiency virus (SHIV-KB9) passaged in vivo | Q39590956 | ||
Properties of the surface envelope glycoprotein associated with virulence of simian-human immunodeficiency virus SHIV(SF33A) molecular clones | Q39682485 | ||
Characterization of CD4-induced epitopes on the HIV type 1 gp120 envelope glycoprotein recognized by neutralizing human monoclonal antibodies | Q40682865 | ||
Rapid development of isolate-specific neutralizing antibodies after primary HIV-1 infection and consequent emergence of virus variants which resist neutralization by autologous sera. | Q45849314 | ||
Mucosal Transmission of Pathogenic CXCR4-Utilizing SHIVSF33AVariants in Rhesus Macaques | Q47682725 | ||
Distinct pathogenic sequela in rhesus macaques infected with CCR5 or CXCR4 utilizing SHIVs | Q53781127 | ||
Fine definition of a conserved CCR5-binding region on the human immunodeficiency virus type 1 glycoprotein 120 | Q73824497 | ||
Interactions of human antibodies, epitope exposure, antibody binding and neutralization of primary isolate HIV-1 virions | Q78599396 | ||
P433 | issue | 4-5 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 211-217 | |
P577 | publication date | 2003-08-01 | |
P1433 | published in | Journal of Medical Primatology | Q15755599 |
P1476 | title | Antigenic variations in the CD4 induced sites of the CCR5-tropic, pathogenic SHIVsf162p3 gp120 variants | |
Antigenic variations in the CD4 induced sites of the CCR5‐tropic, pathogenic SHIVsf162p3 gp120 variants | |||
P478 | volume | 32 |
Q36141515 | Antibodies to CD4-induced sites in HIV gp120 correlate with the control of SHIV challenge in macaques vaccinated with subunit immunogens |
Q34186017 | Cellular gene expression profiles in rhesus macaques challenged mucosally with a pathogenic R5 tropic simian human immunodeficiency virus isolate |
Q36981370 | Comparison of systemic and mucosal immunization with helper-dependent adenoviruses for vaccination against mucosal challenge with SHIV. |
Q34120088 | Immunization with wild-type or CD4-binding-defective HIV-1 Env trimers reduces viremia equivalently following heterologous challenge with simian-human immunodeficiency virus |
Q34974016 | In vitro neutralization of low dose inocula at physiological concentrations of a monoclonal antibody which protects macaques against SHIV challenge |
Q37316026 | Macaca mulatta, fascicularis and nemestrina in AIDS vaccine development. |
Q39582556 | Protection against Mucosal SHIV Challenge by Peptide and Helper-Dependent Adenovirus Vaccines |
Q33737723 | Protection of rhesus monkeys against infection with minimally pathogenic simian-human immunodeficiency virus: correlations with neutralizing antibodies and cytotoxic T cells |
Q34983902 | Repressive effect of primary virus replication on superinfection correlated with gut-derived central memory CD4(+) T cells in SHIV-infected Chinese rhesus macaques |
Q41019959 | Transcription profiling of CD4⁺ T cells in rhesus macaques that infected with simian-human immunodeficiency virus and re-challenged with SIVmac251. |
Q33984326 | V3 loop-determined coreceptor preference dictates the dynamics of CD4+-T-cell loss in simian-human immunodeficiency virus-infected macaques |